Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vir Biotechnology Inc. Common Stock (VIR) vs Teucrium Wheat Fund (WEAT) Price & Performance

Vir Biotechnology Inc. Common StockTrade
Teucrium Wheat FundTrade

Price performance (Past 24H)

Key statistics

Vir Biotechnology Inc. Common Stock vs Teucrium Wheat Fund — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Teucrium Wheat Fund trades at $24.4 (market cap $274.59M). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 6.6× Teucrium Wheat Fund's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Teucrium Wheat Fund for 42 Days on average.

VIRWEAT
Market Cap
$1.80B$274.59M
Volume
1,782,836203,622
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$11.78$28.00
52-Week Low
$5.12$19.88
Typical Hold Time
0 Days42 Days
Enterprise Value
$1.36B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Teucrium Wheat Fund

WEAT trades at $24.28, down 0.74% today, with a bearish technical signal from moving averages. Recent news highlights a 25% year-to-date gain as of July 2026, driven by wheat market dynamics, though inflation concerns persist. Key support is at $24, with resistance at $25. The absence of fundamental ratios like P/E and P/S in the data limits valuation clarity, but the ETF's performance is tied to agricultural commodity trends.

The outlook is cautious due to bearish technical indicators and macroeconomic inflation pressures. Opportunities exist if wheat prices rally, but risks include commodity volatility and Federal Reserve policy impacts. Investors should weigh the ETF's lack of traditional company fundamentals against broader market sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

VIR
51% Buy49% Sell
Avg holding period · 0 Days
WEAT

No sentiment data available yet.

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →

About Teucrium Wheat Fund

WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.

Read more on WEAT →